6.9 out of 10 on Drugs.com, 7.4 for weight loss specifically
Retatrutide is a next-generation investigational peptide that works by targeting three hormone receptors involved in appetite regulation, blood sugar balance, and metabolic activity: GLP-1, GIP, and glucagon receptors
Although its official approval is specific to this group, many providers now use PT-141 more broadly for both men and women who struggle with low libido
Although the research is promising, there are many factors that could potentially impact depression among people with obesity who are taking these medications (weight loss, physical activity, less medical burden, nutritional status, hopefulness, sleep, etc). Semaglutide and tirzepatide were the two medications most strongly related to decreased risk of depression and anxiety
These symptoms may be caused by a deficiency in vitamin B12